Trends in dementia-free life expectancy among elderly members of a large health maintenance organization

International Journal of Epidemiology

Volumn 28, Issue 6, 1999, Pages 1110-1118

  Sauvaget, Catherine ^a   Tsuji, Ichiro ^a   Haan, Mary N ^b   Hisamichi, Shigeru ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Compression and extension of morbidity; Dementia; Health expectancy; Incidence

Indexed keywords

AGED; ARTICLE; COHORT ANALYSIS; DEMENTIA; FEMALE; HUMAN; INCIDENCE; LIFE EXPECTANCY; LIFE TABLE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NORMAL HUMAN; ONSET AGE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE; UNITED STATES;

EID: 0033401413     PISSN: 03005771     EISSN: None     Source Type: Journal    
DOI: 10.1093/ije/28.6.1110     Document Type: Article

References (37)

1. Bachman DL, Wolf PA, Linn R et al. Prevalence of dementia and probable senile dementia of the Alzheimer type in the Framingham Study. Neurology 1992;42:115-19.
2. Canadian Study of Health and Aging Working Group. Canadian Study of Health and Aging: study methods and prevalence of dementia. Can Med Assoc J 1994;150:899-913.
3. Eastwood MR, Rifat SL, Roberts D. The epidemiology of dementia in North America. Eur Arch Psy Clin N 1991;240:207-11.
4. Evans DA, Funkenstein HH, Albert MS, Scherr PA, Cook NR, Chown MJ. Prevalence of Alzheimer's Disease in a community population of older persons. Higher than previously reported. JAMA 1989;262: 2551-56.
5. Gauthier S, McDowell I, Hill G. Canadian Study of Health and Aging (CaSHA). Psychiatr J Univ Ottawa 1990;15:227-29.
6. Kramer M, German PS, Anthony JC, Von Korff M, Skinner EA. Patterns of mental disorders among the elderly residents of Eastern Baltimore. J Am Geriatr Soc 1985;33:236-45.
7. Robertson D, Rockwood K. Stolee P. The prevalence of cognitive impairment in an elderly Canadian population. Acta Psychiat Scand 1989;80:303-09.
8. Weissman MM, Myers JK, Tischler GL et al. Psychiatric disorders (DSM-III) and cognitive impairment among the elderly in a US urban community. Acta Psychiatr Scand 1985;71:366-79.
9. Lilienfeld DE, Perl DP. Projected neurodegenerative disease mortality in the United States, 1990-2040. Neuroepidemiology 1993;12:219-28.
10. Robine J-M, Ritchie K. Healthy life expectancy: evaluation of global indicator of change in population health. Br Med J 1991;302: 457-60.
11. Kramer M. The rising pandemic of mental disorders and associated chronic diseases and disabilities. Acta Psychiatr Scand 1980;62: 382-97.
12. Fries JF. Aging, natural death, and the compression of morbidity. N Engl J Med 1980;303:130-35.
13. Fries JF. The compression of morbidity: near or far? Milbank Q 1989; 67:208-32.
14. Manton KG. Changing concepts of morbidity and mortality in the elderly population. Milbank Q 1982;60:183-244.
15. Perenboom RJM, Boshuizen HC, Breteler MMB, Ott A, van de Water HPA. Dementia-free life expectancy (DemFLE) in The Netherlands. Soc Sci Med 1996;43:1703-07.
16. Ritchie K, Jagger C, Brayne C, Letenneur L. Dementia-free life expectancy: preliminary calculations for France and the United Kingdom. In: Robine J-M, Mathers C, Bone M, Romieu I (eds). Calculation of Health Expectancy: Harmonization, Consensus Achieved and Future Perspectives. Colloques INSERM/John Libbey Eurotext Ltd 1993;226:233-44.
17. Ritchie K, Robine J-M, Letenneur L. Dartigues J-F. Dementia-free life expectancy in France. Am J Public Health 1994;84:232-36.
18. Ritchie K, Mathers C, Jorm A. Dementia-free life expectancy in Australia. Aust J Public Health 1994;18:149-52.
19. Roelands M, van Oyen H, Baro F. Dementia-free life expectancy in Belgium. Eur J Public Health 1994;4:33-37.
20. Sauvaget C. Tsuji I, Minami Y et al. Dementia-free life expectancy among elderly Japanese. Gerontology 1997;43:168-75.
21. Haan MN, Selby JV, Quesenberry CP, Schmittdiel JA, Fireman BH, Rice DP. The impact of aging and chronic disease on use of hospital and outpatient services in a large HMO: 1971-1991. J Am Geriatr Soc 1997;45:667-74.
22. Verbrugge LM. Longer life but worsening health? Trends in health and mortality of middle-aged and older persons. Milbank Mem Fund Qly/Health Soc 1984;62:475-519.
23. Haan MN, Selby JV, Rice DP et al. Trends in cardiovascular disease incidence and survival in the elderly. Ann Epidemiol 1996;6:348-56.
24. Katz S, Branch LG, Branson MH, Papsidero JA, Beck JC, Greer DS. Active life expectancy. N Engl J Med 1983;309:1218-24.
25. Heyman A, Fillenbaum G, Prosnitz B, Raiford K, Burchett B, Clark C. Estimated prevalence of dementia among elderly black and white community residents. Arch Neurol 1991;48:594-98.
26. Schoenberg BS, Anderson DW, Haerer AF. Severe dementia. Prevalence and clinical features in a biracial US Population. Arch Neurol 1985;42:740-43.
27. Fillenbaum GG, Heyman A, Huber MS et al. The prevalence and 3-year incidence of dementia in older black and white community residents. J Clin Epidemiol 1998;51:587-95.
28. Bachman DL, Wolf PA, Linn RT et al. Incidence of dementia and probable Alzheimer's Disease in a general population: the Framingham Study. Neurology 1993;43:515-19.
29. Schoenberg BS, Kokmen E, Okasaki H. Alzheimer's Disease and other dementing illnesses in a defined United States population: incidence rates and clinical features. Ann Neurology 1987;22:724-29.
30. Ritchie K. International comparisons of dementia-free life expectancy: a critical review of the results obtained. In: Mathers C, McCallum J, Robine J-M (eds). Advances in Health Expectancies: Proceedings of the 7th Meeting of the International Network on Health Expectancy (REVES). Canberra, February 1994. Australian Institute of Health and Welfare: AGPS, Canberra, 1994, pp.271-79.
31. Fox P. From senility to Alzheimer's Disease: the rise of the Alzheimer's Disease movement. Milbank Q 1989;67:58-102.
32. Tang M-X, Jacobs D. Stern Y et al. Effect of oestrogen during menopause on risk and age of onset of Alzheimer's Disease. Lancet 1996; 348:429-32.
33. Paganini-Hill A, Henderson VW. Estrogen deficiency and risk of Alzheimer's Disease. Am J Epidemiol 1994;140:256-61.
34. Haskell SG, Richardson ED, Horwitz RI. The effect of estrogen replacement on cognitive [unction in women: a critical review of the literature. J Clin Epidemiol 1997;50:1249-64.
35. Yaffe K, Sawaya G, Lieberburg I, Grady D. Estrogen therapy in postmenopausal women: effects on cognitive function and dementia. JAMA 1998;279:688-95.
36. Crimmins EM, Saito Y, Ingegneri D. Changes in life expectancy and disability-free life expectancy in the United States. Population and Development Review 1989;15:235-67.
37. van de Water HPA, Boshuizen HC, Perenboom RJM. Health expectancy in the Netherlands 1983-1990. Eur J Public Health 1996;6:21-28.